Overview
"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.".
Dr. Casella is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.
Dr. Casella is board certified in American Board Of Pediatrics. He is actively involved in clinical research, co-authoring 65 peer reviewed articles. Dr. Casella is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
Locations
200 North Wolfe Street, Rubenstein BLDG Lower Level, Rubenstein BLDG Lower Level, Baltimore, MD 21287
Additional Areas of Focus
Dr. Casella has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Johns Hopkins Hospital
Michael Streiff is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Streiff is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Streiff is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.
Frequently Asked Questions about Dr. James F. Casella
How do I make an appointment with Dr. James F. Casella?
You can book an appointment with Dr. James F. Casella by calling their office at 443-997-5437. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. James F. Casella a top-rated expert for Sickle Cell Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. James F. Casella is classified as an Elite expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. James F. Casella specialize in?
While Dr. James F. Casella is a Hematology, they have specific expertise in Sickle Cell Disease, Hemoglobinopathy, and Congenital Hemolytic Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. James F. Casella participate in research or clinical trials?
Yes. Dr. James F. Casella has published 65 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. James F. Casella's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. James F. Casella accept my insurance?
Dr. James F. Casella accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 443-997-5437 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Congenital Hemolytic AnemiaDr. Casella isElite. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Casella isElite. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Casella isElite. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseDr. Casella isElite. Learn about Sickle Cell Disease.
- Distinguished
- AnemiaDr. Casella isDistinguished. Learn about Anemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Casella isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Hemoglobin C DiseaseDr. Casella isExperienced. Learn about Hemoglobin C Disease.
- Hemoglobin E DiseaseDr. Casella isExperienced. Learn about Hemoglobin E Disease.
- Venous Thromboembolism (VTE)Dr. Casella isExperienced. Learn about Venous Thromboembolism (VTE).